CAMP4 Therapeutics
↗Cambridge, USA
CAMP4 Therapeutics is a clinical-stage biopharmaceutical company pioneering a novel approach to programmable therapeutics. The company leverages its proprietary RNA Actuating Platform (RAP) to map regulatory RNAs (regRNAs) and develop antisense oligonucleotide (ASO) therapeutics designed to selectively upregulate gene expression. By amplifying mRNA, CAMP4 aims to restore healthy protein levels and address the underlying causes of over 1,200 genetic diseases characterized by haploinsufficiency or partial loss-of-function.
Founded in 2016 and headquartered in Cambridge, Massachusetts, the company operates at the intersection of genomics, computational biology, and data science. CAMP4 went public on the Nasdaq in October 2024 and is actively advancing a pipeline of first-in-class, disease-modifying treatments for rare genetic disorders, including SYNGAP1-related disorders.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Genetic Medicines / RNA Therapeutics
SIZE & FINANCIALS
Employees:51-200
Founded:2016
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$150M
STOCK
Exchange:NASDAQ
Ticker:CAMP
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:RNA, Antisense Oligonucleotide (ASO)
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:BioMarin (RNA-targeting collaboration), GSK ($400M+ collaboration)
COMPETITION
Position:Emerging
Competitors:Stoke Therapeutics, Verve Therapeutics
LEADERSHIP
Key Executives:
Michael MacLean - Board Member
Scientific Founders:Dr. Richard Young, Dr. Leonard Zon
Board Members:Michael MacLean
LINKS
Website:camp4tx.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CAMP4 Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CAMP4 Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.